Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.845
-0.055 (-1.90%)
Oct 13, 2026, 12:27 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 189.86 million as of October 12, 2026. It is the 37,384th most valuable company in the world and the 511th biggest in Sweden. Its market cap has decreased by 46.27% in one year.
Market Cap
189.86M
Enterprise Value
131.74M
Revenue
7.79M
Global Rank
Country Rank
#511 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 189.86M, an increase of 54.80%. That is a compound annual growth rate of 8.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 189.86M | -25.06% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intervacc AB | 316.62M |
| Xbrane Biopharma AB | 269.93M |
| IRLAB Therapeutics AB | 254.89M |
| Isofol Medical AB | 247.10M |
| Simris Group AB (PUBL) | 188.97M |
| Diamyd Medical AB | 154.21M |
| Xintela AB | 142.54M |
| Abera Bioscience AB | 140.62M |